• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4665478)   Today's Articles (1209)   Subscriber (51666)
For: Ruan DY, Liu FR, Wei XL, Luo SX, Zhuang ZX, Wang ZN, Liu FN, Zhang YQ, Yang JW, Chen ZD, Wang YS, Wang JY, Liang XH, Wu XJ, Zheng YL, Liu J, Shi X, Kumar R, Liu W, Chen B, Zhang DS, Xu RH. Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial. Lancet Oncol 2025:S1470-2045(24)00636-3. [PMID: 39788133 DOI: 10.1016/s1470-2045(24)00636-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2024] [Revised: 10/25/2024] [Accepted: 10/28/2024] [Indexed: 01/12/2025]
Number Cited by Other Article(s)
1
Herbert K, Smyth EC. Expanding therapeutic options targeting claudin-18.2. Lancet Oncol 2025:S1470-2045(24)00710-1. [PMID: 39788132 DOI: 10.1016/s1470-2045(24)00710-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2024] [Accepted: 12/02/2024] [Indexed: 01/12/2025]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA